News US opioid crisis a 'national emergency', says Trump Declaration means potential more resources and power to states and federal agencies.
News FDA advisers reject J&J rheumatoid arthritis drug Expert panel concerned about safety of sirukumab.
News FDA rejects Amgen/UCB osteoporosis drug The FDA has rejected Amgen and UCB’s Evenity (romosozumab) osteoporosis drug after a late-stage trial unexpectedly highlighted a potential cardiac safety risk.
News Endo gives way and withdraws opioid painkiller after FDA pre... Pharma makes decision after FDA intervenes to fight opioid crisis.
News Seattle Genetics halts trials of latest ADC after safety war... Monitoring committee concerned about high death rates.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.